A panel of 40 dermatologists in each of the major EU markets reports on patients on advanced therapies including biologics and small molecule therapies every quarter.
In addition from Q1 2019 Therapy Watch will now be tracking prescription topical treatments in both a secondary care and primary care setting providing broad visibility of the psoriasis market landscape.
Address:
Chester House
Fulham Green
81-83 Fulham High Street
London
SW6 3JW
United Kingdom